MicroRNA Expression In Bladder Cancer: A Ratiometric Approach Identifies Invasive Potential
Main Category: Urology / NephrologyAlso Included In: Cancer / Oncology
Article Date: 14 Jun 2008 - 6:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
ORLANDO, FL (UroToday.com) - One third of recurring non-invasive bladder cancer will be invasive. To date, there is no way of identifying those patients who will have this clinical outcome. The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating non-invasive from invasive disease and to determine the prognostic value of such an expression profile.
Expression profiling of 343 miRNAs was performed in a microarray format using 2 non-invasive and 2 invasive bladder carcinoma cell lines. The differential expression of miRNAs was confirmed using a single molecule detection platform assay within a panel of 14 bladder carcinoma cell lines. Mir-21 and mir-205 expression levels were determined in 53 bladder tumors, (28 non-invasive and 25 invasive) and analyzed using a ratiometric approach. Sensitivity, specificity and a ROC curve were calculated to determine the discriminatory power of the mir-ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to confirm their role in invasion.
Microarray analysis identified 9 miRNAs differentially expressed between non-invasive and invasive cell lines that were confirmed in the platform assay. In an extended cell panel, differential expression involving high mir-21 and low mir-205 expression levels were identified associated with invasive cells. Although expression levels of these miRNAs could not discriminate between non-invasive and invasive tumors, the ratio of mir-21:mir-205 displayed excellent discriminatory power. The analysis of this quotient in 53 bladder tumors, representing non-invasive and invasive bladder lesions, showed an area under the ROC curve of 0.89 with 100% sensitivity and 78% specificity using a cutoff = 1.79 to predict an invasive lesion. Of 6 non-invasive lesions displaying a high mir-21:mir-205 ratio, 5 progressed to invasive disease. Knockdown and forced expression of mir-21 modified the invasive behavior of bladder tumor cell lines in in vitro invasion assays.
The investigators had identified a novel miRNA signature that can be used to generate a mir-21:mir-205 ratiometric score differentiating between non-invasive and invasive lesions. In addition, 5 of 6 patients with non-invasive tumors displaying a high ratiometric score presented at a later time with invasive lesions. Alterations in the expression level of mir-21 in vitro modulated the invasive behavior of bladder tumor cells.
Presented by Brasil Silva Neto, MD, et al., at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/111215.php>
APA
http://www.medicalnewstoday.com/releases/111215.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




